Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment
- Conditions
- Breast Neoplasm
- Registration Number
- NCT01859936
- Lead Sponsor
- Karolinska University Hospital
- Brief Summary
The study is a prospective randomised multicenter trial assessing the additional value of breast MRI in women under 56 years of age with newly diagnosed breast cancer. Will preoperative breast MRI change treatment regimen? Will preoperative breast MRI reduce the number of primary surgeries? Will preoperative breast MRI increase the rate of mastectomies? Will preoperative breast MRI be cost effective?
- Detailed Description
Completed: the study has concluded normally; participants are no longer being examined or treated (i.e., last patient's last visit has occurred)
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 440
- Women under 56 years of age
- Newly diagnosed breast cancer
- Swedish or English speaking
- Claustrophobia
- Pregnancy
- Renal failure
- Metal items in patients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change of treatment plan 14 days Did breast magnetic resonance imaging add information about the tumour that changed primary treatment plan
- Secondary Outcome Measures
Name Time Method Did breast magnetic resonance imaging reduce the number of reoperation during primary management 6 months Did breast magnetic resonance imaging increase the number of mastectomies 6 months Did breast magnetic resonance imaging affect cost 6 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Karolinska Univeristy Hospital
🇸🇪Stockholm, Sweden
Karolinska Univeristy Hospital🇸🇪Stockholm, Sweden